Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro
- PMID: 20610558
- DOI: 10.1124/dmd.110.034835
Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro
Abstract
UDP-glucuronosyltransferases (UGTs) are major mediators in conjugative metabolism. Current data suggest that UGTs, which are anchored in the endoplasmic reticulum membrane, can oligomerize with each other and/or with other metabolic enzymes, a process that may influence their enzymatic activities. We demonstrated previously that the UGT1A locus encodes previously unknown isoforms (denoted "i2"), by alternative usage of the terminal exon 5. Although i2 proteins lack transferase activity, we showed that knockdown of endogenous i2 levels enhanced cellular UGT1A-i1 activity. In this study, we explored the potential of multiple active UGT1A_i1 proteins (UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A7, UGT1A8, UGT1A9, and UGT1A10) to interact with all spliced i2s by coimmunoprecipitation. We further studied the functional consequences of coexpressing various combinations of spliced i1s and i2s from highly similar UGTs, namely UGT1A7, UGT1A8, and UGT1A9, based on expression profiles observed in human tissues. The i1 isoform of each UGT1A coimmunoprecipitated its respective i2 homolog as well as all other i2s, indicating that they can form heteromeric complexes. Functional data further support the fact that i2 splice species alter glucuronidation activity of i1s independently of the identity of the i2, although the degree of inhibition varied, suggesting that this phenomenon may occur in tissues expressing such combinations of splice forms. These results provide biochemical evidence to support the inhibitory effect of i2s on multiple active UGT1As, probably through formation of inactive heteromeric assemblies of i1s and inactive i2s. The relative abundance of active/inactive oligomeric complexes may thus determine transferase activity.
Similar articles
-
Modulation of the human glucuronosyltransferase UGT1A pathway by splice isoform polypeptides is mediated through protein-protein interactions.J Biol Chem. 2010 Feb 5;285(6):3600-3607. doi: 10.1074/jbc.M109.083139. Epub 2009 Dec 8. J Biol Chem. 2010. PMID: 19996319 Free PMC article.
-
Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8.J Biol Chem. 1998 Apr 10;273(15):8719-26. doi: 10.1074/jbc.273.15.8719. J Biol Chem. 1998. PMID: 9535849
-
Immunohistochemical expression of conjugating UGT1A-derived isoforms in normal and tumoral drug-metabolizing tissues in humans.J Pathol. 2011 Feb;223(3):425-35. doi: 10.1002/path.2805. Epub 2010 Oct 29. J Pathol. 2011. PMID: 21171088
-
Alternative-splicing forms of the major phase II conjugating UGT1A gene negatively regulate glucuronidation in human carcinoma cell lines.Pharmacogenomics J. 2010 Oct;10(5):431-41. doi: 10.1038/tpj.2009.64. Epub 2009 Dec 8. Pharmacogenomics J. 2010. PMID: 19997083
-
Identification of uridine diphosphate glucuronosyltransferases involved in the metabolism and clearance of mycophenolic acid.Ther Drug Monit. 2000 Feb;22(1):10-3. doi: 10.1097/00007691-200002000-00002. Ther Drug Monit. 2000. PMID: 10688250 Review.
Cited by
-
Unravelling the transcriptomic landscape of the major phase II UDP-glucuronosyltransferase drug metabolizing pathway using targeted RNA sequencing.Pharmacogenomics J. 2016 Feb;16(1):60-70. doi: 10.1038/tpj.2015.20. Epub 2015 Apr 14. Pharmacogenomics J. 2016. PMID: 25869014
-
Insight into the structure, oligomerization, and the role in drug resistance of human UDP-glucuronosyltransferases.Arch Toxicol. 2025 Mar;99(3):1153-1165. doi: 10.1007/s00204-024-03929-6. Epub 2025 Jan 15. Arch Toxicol. 2025. PMID: 39812829 Review.
-
Endogenous Protein Interactome of Human UDP-Glucuronosyltransferases Exposed by Untargeted Proteomics.Front Pharmacol. 2017 Feb 3;8:23. doi: 10.3389/fphar.2017.00023. eCollection 2017. Front Pharmacol. 2017. PMID: 28217095 Free PMC article.
-
Genetic factors affecting gene transcription and catalytic activity of UDP-glucuronosyltransferases in human liver.Hum Mol Genet. 2014 Oct 15;23(20):5558-69. doi: 10.1093/hmg/ddu268. Epub 2014 May 30. Hum Mol Genet. 2014. PMID: 24879639 Free PMC article.
-
Post-transcriptional Regulation of UGT2B10 Hepatic Expression and Activity by Alternative Splicing.Drug Metab Dispos. 2018 May;46(5):514-524. doi: 10.1124/dmd.117.079921. Epub 2018 Feb 9. Drug Metab Dispos. 2018. PMID: 29438977 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases